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Introduction
Dihydrofolate reductase (DHFR, 5, 6, 7, : NADP+ oxidoreductase, EC 1.51.3) catalyzes the reduction of dihydrofolate to tetrahydrofolate, utilizing NADPH as a cofactor. Tetrahydrofolate and its one-carbon adducts are essential cofactors in the synthesis of thymidylate, purines and some amino acids (Blakley, 1984) . Inhibition of DHFR results in a depletion of the reduced folate pools, inhibition of DNA synthesis, and cell death. MTX, a tight binding inhibitor of DHFR, is used for the treatment of acute lymphocytic leukemia, nonHodgkins lymphoma, osteosarcoma, choriocarcinoma, breast, and head and neck cancer, as well as a variety of other nonmalignant diseases Chu, 1996) .
Within days following exposure to MTX, DHFR activity increases approximately six fold in blast cells of leukemic patients (Bertino et al., 1962) . Following this initial report, several studies of human cells in vivo and in vitro showed that DHFR protein levels rapidly increase, or are "induced", in response to MTX treatment (Bertino et al., 1962; Bertino et al., 1963; Hillcoat and Bertino, 1969; Hillcoat et al., 1967a) . This rapid adaptive response differs from the increase in DHFR due to gene amplification in cells after long term MTX selection (Alt et al., 1978) . The rapid increase in DHFR protein levels seen upon exposure to MTX was unaffected by the transcriptional inhibitor actinomycin D, but was blocked by the translational inhibitor cycloheximide (Hillcoat et al., 1967a; Hillcoat et al., 1967b) ruling out an increase in transcription as the mechanism. As the increase in DHFR is associated with MTX bound to the protein, it was suggested that MTX protected DHFR from degradation (Bertino et al., 1970) .
Later studies showed that the half-life of DHFR protein was unaltered in the presence of MTX (Cowan et al., 1986; Domin et al., 1982) , indicating that protection from degradation was not the explanation for the increase. The first suggestion that translational regulation may play a role in DHFR induction came from studies showing that DHFR mRNA levels remain the same in the presence or absence of MTX (Bastow et al., 1984; Cowan et al., 1986) . Based on studies demonstrating an interaction between DHFR protein and its cognate mRNA, a model was proposed to account for increases in DHFR protein levels in response to MTX exposure, namely that the binding of human DHFR protein to its cognate mRNA results in decreased translation, and that addition of MTX disrupts this auto-regulation (Chu et al., 1993; Ercikan et al., 1993) . Using an in vitro translation assay our laboratory (Ercikan et al., 1993) and Chu et al (Chu et al., 1993) demonstrated that addition of exogenous DHFR protein in a rabbit reticulocyte system inhibited translation of DHFR mRNA. Utilizing both RNA gel shift assays and UV cross-linking competition studies, the DHFR binding site was localized to a 100 base pair region in the coding region between nucleotides 380-480 (Ercikan-Abali et al., 1997) . Computer modeling of mRNA folding in this region revealed two possible stem-loop structures suitable for DHFR binding between nucleotides 407-470. We postulated that DHFR binds to its own mRNA within this coding region resulting in repression of translation. The addition of inhibitor, substrate, or co-factor alters DHFR conformation, resulting in disruption of this RNA-protein complex and subsequent resumption of translation (Ercikan-Abali et al., 1997) . Tai et al. (Tai et al., 2004a ) using gel shift and nitrocellulose filter binding assays subsequently localized the binding site to an 82-nucleotide sequence corresponding to nucleotides 401-482, consistent with our initial findings.
In this report we show that DHFR induction by MTX differs between human and rodent cells. While there is an increase in DHFR protein levels in human cell lines in response to MTX treatment, there is no change in DHFR protein levels in either mouse or hamster cells upon MTX treatment. We attribute this difference to differences in the protein structure of DHFR between This article has not been copyedited and formatted. The final version may differ from this version. Tissue culture and transfections. The Chinese hamster ovary cell line DG44, deleted for both alleles of DHFR, was a kind gift of Dr. L. Chasin (Columbia University, New York, NY).
Parental DG44 cells were maintained in CMRL 1066 media supplemented with 10% FBS, 100 units/ml penicillin, and 100 μg/ml streptomycin. Human (C85), hamster (CHO) and mouse (3T6) cells were grown in RPMI 1640 supplemented with 10% FBS, 100 units/ml penicillin, and 100 μg/ml streptomycin. All transfections were performed using DOTAP transfection reagent (Roche Western Blotting. Protein samples were resolved on 10% SDS-PAGE gels. Transfer was performed by standard electroblotting protocols onto nitrocellulose membranes. Equal loading was determined by using Ponceau S and anti-β tubulin antibody. Immunoblots were incubated with anti-EGFP, anti-DHFR, anti-GAPDH or anti-β-tubulin antibodies at room This article has not been copyedited and formatted. The final version may differ from this version. Cytotoxicity Assay. Cytotoxicity to antifolates was determined by the 3-(4,5-dimethylthiazol-2- In-vitro transcription and translation assay. DHFR-EGFP constructs were generated with PCR using a primer at the 5'end that the T7 promoter. After phenol chloroform extraction and precipitation of the PCR products using 90% ethanol, in vitro transcription was performed using T7 RNA polymerase according to the manufacturer's instruction (Promega, Madison, WI). The integrity and the size of the RNA were verified using gel electrophoresis, and the concentration and the purity of RNA samples were determined by reading the absorbance at λ=260 nm and taking the ratio of λ=260 nm to λ=280 nm respectively.
The nuclease treated rabbit reticulocyte lysate system (Promega, Madison, WI) was used to translate the in-vitro transcribed RNA samples. 7.5 pmol of each transcript, 23 μL rabbit reticulocyte lysate, 40 U rRNAsin inhibitor, 1mM amino acid mixture which lacked methionine, MOL #55772 11 added and the reaction mixture was incubated for 30 min at 37°C. The cell free translation products were run on a 12% SDS-PAGE gel and autoradiographed for visualization.
Flow cytometry. Expression of EGFP after 1 μM MTX treatment for 48 h was determined using flow cytometry. After trypsinization of the DHFR-EGFP transfected DG44 cells, the cells were washed and suspended in media. Cytometric analysis was performed using FACSCalibur (BD Biosciences, San Jose, CA) equipped with CellQuest software. EGFP fluorescence was detected using a 525/50 band pass filter. The induction efficiency of variants of DHFR is expressed as a percentage (the number of cells expressing EGFP over the total number of cells).
Measurement of DHFR activity.
The specific activity of DHFR from lysates of hamster and the variants of human DHFR-EGFP was determined as described by Ercikan-Abali (1996) .
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Results
Rodent DHFR levels do not increase in the presence of antifolates. DHFR protein levels are up regulated in response to MTX in all human cell lines tested (Bastow et al., 1984; Bertino et al., 1962; Chu et al., 1993; Cowan et al., 1986; Ercikan-Abali et al., 1997) . In contrast, there was no detectable increase in DHFR levels in hamster (CHO) and mouse (3T6) cell lines following exposure to 100 nM MTX for 24 or 48 h, while DHFR protein levels were increased in a human colon cancer cell line, C85 ( Figure 1a) .
We considered several possible explanations for the difference in response of hamster versus human cells following exposure to MTX. Although DHFR levels are regulated at both the transcriptional and translational level, we had previously shown that steady state levels of DHFR mRNA are not altered by MTX in either hamster or human cells, suggesting that differential regulation occurs downstream of RNA synthesis/degradation, perhaps at the level of translation. Translation of DHFR mRNA is controlled by sequences within the coding region and the 3'UTR (Mishra et al., 2007) . In order to determine whether the differential response to MTX was regulated by differences in the coding region, chimeric constructs of either human or hamster DHFR coding region fused to EGFP and under the control of the constitutive CMV promoter were constructed. Using a functional rapid fluorescence assay, we tested the relative increase in EGFP fluorescence of the two DHFR-EGFP fusion proteins; EGFP alone was used as a negative control to set the baseline fluorescence. As shown in Figure 1b , there was a specific increase (>2-fold) in the human DHFR-EGFP fusion protein levels in response to MTX treatment. However, when hamster DHFR-EGFP was transfected into the DG44 cell line, there was no detectable increase in fusion protein levels in response to MTX treatment (Figure 1b and c). Moreover, the three mutants of human DHFR (S118A, L22R and E30A) that are not This article has not been copyedited and formatted. The final version may differ from this version. (Skacel, 2004) were also not increased in response to MTX ( Figure 1b) . We had previously reported that a mutant DHFR, with its sole cysteine residue changed to either serine or glycine, increased after treatment with MTX and trimetrexate (an antifolate with similar affinity towards DHFR as MTX), but not after treatment with raltitrexed (with thymidylate synthase as its major target (K i = 1 nM), and DHFR as a secondary target (K i = 92 nM) (29) or pemetrexed (pemetrexed-polyglutamates potently inhibit both thymidylate synthase (K i = 1.3 nM) and DHFR (K i = 7.2 nM) and to a lesser extent, 5-phosphoribosylaminoimidazolecarboxamide transformylase (GARFT) (K i = 65 nM) ) (Skacel et al., 2005) . We therefore determined whether DHFR from hamster cells would also show differences in upregulation to various antifolates. Hamster DHFR-EGFP transfected cells exposed to MTX, trimetrexate, raltitrexed and pemetrexed did not show an increase in DHFR , similar to what had been observed for the DHFR mutants that lack negative feedback regulation of DHFR translation (Figure 1d ).
Lack of upregulation of rodent DHFR by antifolates is due to failure of hamster DHFR
protein to bind to its cognate mRNA. The current model for translational regulation of DHFR by its cognate mRNA is that DHFR protein interacts through its NADPH binding site within the coding region of its own mRNA (nucleotides 380-480). We proposed that DHFR exists in at least two conformers, one of which has higher affinity for NADPH and the other for DHFR 14 upregulation by these mutants may be due to a change in their protein structure rather than s difference in their mRNAs. As both the protein and mRNA sequence of hamster DHFR differs from human DHFR, we investigated the role of each in the divergent regulation of human and rodent DHFR. To accomplish this, we initially compared the cis-acting regulatory elements on hamster DHFR mRNA with those of human wt and non-RNA binding mutant DHFR mRNAs.
Our earlier work and studies by Tai et al (Tai et al., 2004b) demonstrated that the DHFR binding site was localized to a 100 base pair sequence in the coding region between nucleotides 380-480.
Analysis of human DHFR mRNA in this region using the mfold program (Zuker and Stiegler, 1981) revealed two potential stem-loop structures which could form stable secondary structures suitable for DHFR protein binding (ΔG = -12.3 kcal/mol). The difference between hamster and human DHFR in the predicted stem-loop structure is only four nucleotides with 89% homology.
Although the hamster DHFR RNA also formed two similar stem-loop structures, the stability of these two stem loops was lower than the stability of the human stem loops (ΔG=-6.1 vs ΔG=-12.3 kcal/mol). Therefore, we hypothesized that the difference in RNA folding due to four nucleotides differences between human and hamster within this binding region may be responsible for the lack of translational up-regulation of hamster DHFR by antifolates (Figure 2 a and b). In order to test this hypothesis, we "hamsterized" the human DHFR-EGFP fusion construct within the region that forms the putative two stem-loop structures by changing the four nucleotides in the human DHFR to the hamster nucleotides. The hamsterized human DHFR-EGFP was transfected into the DG44 cell line and clones, as well as batches, were selected by resistance to G418 and stable cell lines were generated. Transfected cells were exposed to l µM of MTX or media without MTX for 24 h and 48 h and the fusion protein levels were detected using an anti-EGFP antibody. As shown in Figure Earlier studies indicated that the putative DHFR mRNA binding site is localized to a larger stretch of nucleotides (100 bp) than just the nucleotides that formed the stem loop structures (Ercikan-Abali et al., 1997; Tai et al., 2004a) . Therefore, we also examined the role of the nucleotides that are not part of the stem and loop structures but still lie within the l00bp-binding region. Figure 3a shows the sequence of the entire putative binding site that includes nucleotides 380-480 within the coding region compared to the hamster DHFR sequence within the same region. There are four-nucleotide differences upstream of the stem and loop structures and one nucleotide difference downstream. We denoted the "hamsterized" part of the binding region as the core binding region and using this construct, we performed additional rounds of site-directed mutagenesis using the hamsterized human DHFR-EGFP as the template, generating three additional chimeric constructs. One construct, a "half-mutated" binding region ( We began to test this new hypothesis by analyzing a number of human DHFR mutants that alter the amino acid sequence. Tai and colleagues showed that a mutation in nucleotide 419
(U to C) dramatically reduced the binding of wt human DHFR to its cognate mRNA (Tai et al., 2004b) . However it was not clear whether the loss of binding between DHFR protein with its cognate mRNA correlated with the loss of MTX-induced translational regulation. Therefore we created the same mutation and tested its ability to be induced by MTX. As shown in Figure 4 , DHFR 419 U→C, (DHFR M140T mutant) was still up regulated by MTX. We then examined the human DHFR S118A mutant that has similar characteristics as hamster DHFR, i.e. both are not up regulated by MTX (Figure 5a ). DG44 cells that were already transfected with the mutant S118A-EGFP were transfected with a flag-tagged wt DHFR protein expression vector. This allowed us to observe the changes in both human wt and mutant DHFR protein (Figure 5b ). Five individual cell lines established from stable transfectants containing both flag-tagged DHFR and the mutant S118A-EGFP demonstrated increased fusion protein levels upon exposure to 1µM
MTX for 24 h. The levels of S118A-EGFP fusion protein increased in response to MTX comparable with flag-tagged wt DHFR in the doubly transfected cell lines. Moreover, the basal level of S118A protein levels in doubly transfected cell lines were significantly reduced as compared to the singly transfected cell line indicating the restoration of negative feedback regulation of the human DHFR S118A mutant by expression of wt human DHFR in these cells.
This article has not been copyedited and formatted. The final version may differ from this version. Hence, introduction of wt human DHFR into the S118A transfected cells re-established the ability of this mutant to be induced by MTX (Figure 5a and b) .
In a second experiment, we used a metastatic human colon cancer cell line (C85) in which the endogenous DHFR levels are up regulated by MTX (Figure 1a ). These cells were transfected with either wt human or hamster DHFR-EGFP and batches resistant to G418 were expanded. Polyclonal DHFR antibody was used to detect endogenous human DHFR and anti-EGFP antibody was used to detect the fusion protein of wt hamster DHFR-EGFP. When these cells were exposed to 0.1 or 1 µM MTX for 48 h there was a marked increase in hamster DHFR-EGFP protein levels in response to MTX treatment ( Figure 5c ). Thus, in the presence of human DHFR protein, hamster DHFR protein was now induced by MTX, indicating that human DHFR protein is somewhat promiscuous, i.e. it also binds to DHFR hamster DHFR mRNA and inhibits its synthesis, similar to the results obtained with the human DHFR S118A variant that is not responsive to MTX-induced upregulation (Figure 5a ). Therefore wt human DHFR protein by binding to both wt hamster DHFR and the human DHFR S118A variant mRNA regulated the translation of these mRNAs and DHFR levels were increased in the presence of MTX.
Translational regulation of human DHFR by MTX is an intrinsic mechanism of resistance.
Cells transfected with the three human DHFR mutants that lacked translational feedback regulation had a higher cellular baseline level of DHFR than cells transfected with wt DHFR (Skacel, 2004) , As hamster DHFR baseline levels are also high, we hypothesized that the reason for the increased level of DHFR in hamster cells as compared to human cells was a difference in translation efficiency. Therefore we compared the translational efficiency of hamster and human mutant DHFR mRNAs. When equal concentrations of in vitro transcribed DHFRs (human wt, S118A, L22R, E30A and hamster DHFR transcripts) were prepared and This article has not been copyedited and formatted. The final version may differ from this version. translated using a rabbit reticulocyte assay, the human mutant and hamster wt DHFR transcripts were translated to a greater extent than wt human DHFR mRNA (Figure 6a ). The half-life of the mutant and the wt human and hamster DHFRs were compared. After treating the transfected DG44 cells with cycloheximide to inhibit protein synthesis, cell lysates were collected at different time points and DHFR levels were analyzed using Western blotting. There was no significant difference in half-lives among the mutants of human DHFR that are not induced by MTX, wt human and hamster DHFR (data not shown). Therefore, the higher basal levels of the variants of human DHFR and hamster DHFR may be attributed to the fact that these proteins do not bind to their own mRNA to inhibit translation. Next, we determined the basal levels and specific activity of DHFR in DG44 cells transfected with either wt human DHFR-EGFP or wt hamster DHFR-EGFP. The basal levels were established by titrating wt hamster DHFR levels and by comparing 30 μg of total lysate of wt human DHFR with wt hamster DHFR (Figure 6b ).
The basal level of wt hamster DHFR was 10-fold higher than that of wt human DHFR transfectants. In addition, DHFR protein levels were comparable to the specific activity obtained for human and hamster DHFR (Figure 6c ). The kinetic properties of human and hamster DHFR are similar (the Km of dihydrofolate for human and hamster DHFR are 0.02-0.37 μM and 0.42 μM, respectively and the Kms for NADPH for human and hamster are 0.16-1.44 μM and 0.64 μM, respectively (Ercikan-Abali et al., 1996; Lewis et al., 1995; Schweitzer et al., 1989; Wu et al., 1997) ). In addition, there was no statistical difference (p=0.26) in the ED50 values for MTX between DG44 transfectants of human and hamster DHFR when one-tailed paired t-test was used to analyze the data using Graph Prism 4 (Figure 6d ). The observation that hamster DHFR is expressed at ~10 times the level of human DHFR, but human DHFR is induced ~ 10-fold by
MTX indicates that human cells respond to MTX by translationally upregulating DHFR levels
This article has not been copyedited and formatted. The final version may differ from this version. and that this mechanism is an intrinsic mechanism of resistance to antifolates. Hence, the upregulation of DHFR protein in the presence of MTX leads to decreased sensitivity to this drug.
Discussion
Earlier, we observed that DHFR in rodent (mouse and hamster) cells did not increase following MTX treatment as compared to DHFR levels in human, monkey and dog cells (Skacel, 2004) . Herein, we demonstrate that this is due to a critical difference in the translational regulation of human and rodent DHFR. Based on the aforementioned model, we considered two explanations for the lack of MTX-induced translational regulation of hamster DHFR: i) a difference between the cis-acting regulatory elements on hamster versus human DHFR mRNA or ii) a difference in the trans-acting regulatory domain of hamster DHFR versus human DHFR.
To test the first possibility, we compared the human DHFR mRNA cis element to that of the hamster. Target elements for RNA binding proteins are generally found in loops, bulges or interior loops, which offer conformations for recognition and binding (reviewed in Frankel, 2000) . Modeling studies using Zuker's RNA m-fold program identified two putative stem and loop structures within this region for both species. However, these structures had significant species-specific differences in their predicted stability, with the human structures approximately twice as stable as the comparable structures in rodent DHFR mRNA structures. The bulges within these structures were also dissimilar. However, "hamsterizing" the human protein by replacing the human sequence with the respective hamster nucleotides had no affect on the ability of MTX to upregulated the hamsterized DHFR, strongly suggesting that the observed difference in DHFR mRNA structure was not the explanation for the lack of upregulation of hamster DHFR.
Next we addressed the second possibility i.e. that the divergent translational regulation between hamster and human DHFR is due to the differences in the trans-acting regulatory (i.e.
protein) domains between human and hamster DHFR. Previously, we identified a variant of This article has not been copyedited and formatted. The final version may differ from this version. human DHFR (S118A) residing in the NADPH binding pocket was similar to wt human DHFR in its enzymatic properties and yet was not upregulated by MTX (Skacel et al., 2005) . We hypothesized that this human DHFR mutant might mimic the hamster DHFR, perhaps in a shared inability to bind to DHFR mRNA, thereby effecting translational control. If this were the case, the wild type human DHFR protein should be able to compensate for the hamster and S118A defects, bind to their respective mRNAs and regulate their translation. Using cotransfection experiments, we indeed showed that both hamster and S118A DHFR protein levels were elevated after MTX administration in the presence of wt human DHFR, strongly implicating differences in DHFR protein/conformation in the lack of a translational autoregulatory mechanism for the mutant and hamster DHFR is sequence. By extrapolation, human DHFR protein is an RNA-binding protein, while hamster is not. These findings also may explain the increased basal levels of hamster DHFR protein and variants of human DHFR that are not upregulated by MTX (Skacel et al., 2005) . There is growing evidence that many enzymes have additional regulatory functions that are not related to their enzymatic activities. These enzymes have been referred to as "moonlighting" enzymes (Jeffery, 1999) . Thus the ability of DHFR to regulate its translation would indicate that DHFR may also be a moonlighting enzyme.
The involvement of the DHFR NADPH binding site in autoregulation of DHFR through RNA binding is notable, but not unprecedented. A number of dehydrogenases have been shown to interact with RNA through their NAD/NADPH binding sites (Hentze, 1994; Nagy et al., 2000) . One of the most noteworthy, glyceraldehyde-3-phosphate dehydrogenase, binds tRNA, AU-rich sequences at the 3'untranslated region of mRNA, hammerhead ribozyme and viral cisacting regulatory elements (Evguenieva-Hackenberg et al., 2002) . The possibility that human DHFR may bind to other mRNA species is currently being explored.
This article has not been copyedited and formatted. The final version may differ from this version. is a rapid adaptive mechanism of resistance. While this mechanism may protect normal renewal tissues from the toxicity of MTX, it may also decrease the sensitivity of tumor cells to therapy.
This adaptive mechanism of human DHFR was also shown with pyrimethamine, an antifolate that is used in the treatment of malaria. The malaria parasite, Plasmodium falciparum, has a bifunctional DHFR-thymidylate synthase enzyme synthesized from the same mRNA transcript.
This transcript binds to the bifunctional enzyme, but administration of antifolates for the treatment of malaria does not release DHFR-TS mRNA from binding to its protein Therefore, while the parasite is killed by pyrimethamine, the ability of the human host to upregulate DHFR allows the host to overcome drug toxicity by increasing human DHFR protein levels (Zhang and Rathod, 2002) .
We conclude that divergent translational regulation of human and hamster DHFR is due to the differences in their protein properties rather than differences in their mRNAs (Figure 7 ).
Not only does human DHFR bind to its cognate mRNA, but also it binds to hamster DHFR mRNA. wt human DHFR. While flag-tagged wt human DHFR protein levels were detected with anti-flag antibody, mutant DHFR S118A-EGFP levels were detected with anti-EGFP antibody. Five stable clones of doubly transfected cell lines were exposed to 1µM MTX for 48 h and DHFR protein were detected using Western blotting. Graph is depicting the quantitative analysis of the data in (b). The intensity of DHFR S118A-EGFP protein bands was normalized to the intensity of GAPDH. c) C85 cells transfected with hamster DHFR-EGFP were exposed to 0.l and 1µM
MTX for 48 h. 50 µg of total cell lysate was loaded and probed with either DHFR antibody for endogenous levels of wt human DHFR and EGFP antibody for wt hamster-EGFP fusion protein.
To control for equal loading, blots were stripped and reprobed with an α-tubulin antibody. which preferentially is bound to NADPH, and the other is bound to DHFR mRNA. These two conformers are in equilibrium and can interconvert. Binding of MTX to the binary complex of DHFR-NADPH shifts the equilibrium towards the NADPH bound conformer, releasing DHFR mRNA to be translated. However, three variants of human DHFR protein (S118A, L22R and E30A) and hamster are unable to bind their own cognate mRNA which leads to increased synthesis of these proteins. Therefore, while binding of MTX to the wt human DHFR-mRNA complex leads to resumption of DHFR synthesis, hamster and three variants of human DHFR proteins are not induced by MTX.
